Clinical Binding Properties, Internalization Kinetics, and Clinicopathologic Activity of Brentuximab Vedotin: An Antibody-Drug Conjugate for CD30-Positive Lymphoid Neoplasms.

Publication Type:

Journal Article

Source:

Clinical lymphoma, myeloma & leukemia (2012)

Keywords:

2012, Clinical Research Division, May 2012